Ulrich Jäger

14.7k total citations · 1 hit paper
172 papers, 5.7k citations indexed

About

Ulrich Jäger is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Ulrich Jäger has authored 172 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Hematology, 54 papers in Oncology and 53 papers in Genetics. Recurrent topics in Ulrich Jäger's work include Acute Myeloid Leukemia Research (38 papers), Lymphoma Diagnosis and Treatment (38 papers) and Chronic Lymphocytic Leukemia Research (37 papers). Ulrich Jäger is often cited by papers focused on Acute Myeloid Leukemia Research (38 papers), Lymphoma Diagnosis and Treatment (38 papers) and Chronic Lymphocytic Leukemia Research (37 papers). Ulrich Jäger collaborates with scholars based in Austria, Germany and United States. Ulrich Jäger's co-authors include Klaus Lechner, Peter Valent, Andreas Chott, Ilse Schwarzinger, Klaus Geißler, Wolfgang R. Sperr, Johannes Drach, Paul Knöbl, Berthold Streubel and Heinz Gisslinger and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Ulrich Jäger

169 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting

2019 286 citations Ulrich Jäger, Wilma Barcellini et al. profile →

Peers

Countries citing papers authored by Ulrich Jäger

Since Specialization

Citations

This map shows the geographic impact of Ulrich Jäger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Jäger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Jäger more than expected).

Fields of papers citing papers by Ulrich Jäger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Jäger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Jäger. The network helps show where Ulrich Jäger may publish in the future.

Co-authorship network of co-authors of Ulrich Jäger

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Jäger. A scholar is included among the top collaborators of Ulrich Jäger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Jäger. Ulrich Jäger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Parsaclisib for the treatment of primary autoimmune hemolytic anemia: Results from a phase 2, open‐label study 2024 ·American Journal of Hematology ·Wilma Barcellini, Fabrizio Pane, Andrea Patriarca, (unknown), Louis Terriou, Maria T. DeSancho, Wahid T. Hanna, Lance Leopold, Erica Rappold, (unknown), (unknown), Ulrich Jäger	2
2	N‐terminal pro‐brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia 2023 ·American Journal of Hematology ·(unknown), Georg Greiner, Rodrig Marculescu, Karoline V. Gleixner, Susanne Herndlhofer, Gabriele Stefanzl, Paul Knoebl, Ulrich Jäger, Alexander W. Hauswirth, Ilse Schwarzinger, Renate Thalhammer, Michael Kundi, Gregor Hoermann, Gerlinde Mitterbauer‐Hohendanner, Peter Valent, Wolfgang R. Sperr	5
3	Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine 2022 ·Blood Cancer Discovery ·Tim Heinemann, Christoph Kornauth, Yannik Severin, Gregory I. Vladimer, Tea Pemovska, Emir Hadzijusufovic, Hermine Agis, Maria‐Theresa Krauth, Wolfgang R. Sperr, Peter Valent, Ulrich Jäger, Ingrid Simonitsch‐Klupp, Giulio Superti‐Furga, Philipp B. Staber, Berend Snijder	11
4	In Human Visualization of Ibrutinib-Induced CLL Compartment Shift 2020 ·Cancer Immunology Research ·Marius E. Mayerhoefer, Alexander Haug, Ulrich Jäger, Verena Pichler, Sarah Pfaff, Hans‐Jürgen Wester, Marcus Hacker, Lukas Kazianka, Philipp B. Staber	8
5	Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL 2020 ·Cells ·Rainer Hubmann, Susanne Schnabl, (unknown), Christian Schmidl, André F. Rendeiro, Martin Hilgarth, Dita Demirtas, (unknown), Philipp B. Staber, Peter Valent, Christoph Zielinski, Ulrich Jäger, Medhat Shehata	9
6	Review of cancer treatment with immune checkpoint inhibitors 2017 ·Wiener klinische Wochenschrift ·Christiane Thallinger, Thorsten Füreder, Matthias Preusser, Gerwin Heller, Leonhard Müllauer, Christoph Höller, Helmut Prosch, (unknown), (unknown), Walter Berger, Ulrich Jäger, Christoph Zielinski	100
7	Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas 2015 ·Medicine ·Ana‐Iris Schiefer, Christoph Kornauth, Ingrid Simonitsch‐Klupp, Cathrin Skrabs, Eva Katharina Masel, Berthold Streubel, Katrina Vanura, Karin Walter, (unknown), Dagmar Stoiber, Veronika Sexl, Markus Raderer, Andreas Chott, María Gomes da Silva, José Cabeçadas, Leonhard Müllauer, Ulrich Jäger, Edit Porpaczy	19
8	Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma 2014 ·Thrombosis Research ·Johanna Gebhart, Klaus Lechner, Cathrin Skrabs, Thamer Sliwa, Ercan Müldür, H. Ludwig, Thomas Nösslinger, Katrina Vanura, Κώστας Σταματόπουλος, Ingrid Simonitsch‐Klupp, Andreas Chott, Peter Quehenberger, Gerlinde Mitterbauer‐Hohendanner, Ingrid Pabinger, Ulrich Jäger, Katharina Geißler	13
9	Screening for adenoviruses in haematological neoplasia: High prevalence in mantle cell lymphoma 2013 ·European Journal of Cancer ·Karin Kosulin, Margit Rauch, Peter F. Ambros, Ulrike Pötschger, Andreas Chott, Ulrich Jäger, Johannes Drach, Alexander Nader, Thomas Lion	6
10	Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen 2012 ·Blood ·Christoph Steininger, George F. Widhopf, Emanuela M. Ghia, Christopher S. Morello, Katrina Vanura, Rebecca Sanders, Deborah H. Spector, (unknown), Ulrich Jäger, Thomas J. Kipps	46
11	Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience 2012 ·Blood ·Achim Rothe, Stephanie Sasse, Helen Goergen, Dennis A. Eichenauer, Andreas Lohri, Ulrich Jäger, Christopher Bangard, Boris Böll, (unknown), Sebastian Theurich, Peter Borchmann, Andreas Engert	60
12	Neoplastic stem cells: Current concepts and clinical perspectives 2010 ·Critical Reviews in Oncology/Hematology ·Axel Schulenburg, (unknown), Harald Herrmann, Heidrun Karlic, Irina Mirkina, Rainer Hubmann, Sylvia Laffer, Brigitte Marian, Medhat Shehata, Clemens Krepler, Hubert Pehamberger, Thomas W. Grunt, Ulrich Jäger, Christoph Zielinski, Peter Valent	27
13	Recombinase, chromosomal translocations and lymphoid neoplasia: Targeting mistakes and repair failures 2006 ·DNA repair ·Rodrig Marculescu, Katrina Vanura, Bertrand Montpellier, Sandrine Roulland, Trang Le, Jean‐Marc Navarro, Ulrich Jäger, Fraser McBlane, Bertrand Nadel	66
14	Lymphoma-Specific Genetic Aberrations in Microvascular Endothelial Cells in B-Cell Lymphomas 2004 ·New England Journal of Medicine ·Berthold Streubel, Andreas Chott, Daniela Hüber, Markus Exner, Ulrich Jäger, Oswald Wagner, Ilse Schwarzinger	249
15	<sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography (<sup>18</sup>F-FDG-PET) for Staging and Follow-Up of Marginal Zone B-Cell Lymphoma 2003 ·Oncology ·Martha Hoffmann, Kurt Kletter, Alexander Becherer, Ulrich Jäger, Andreas Chott, Markus Raderer	93
16	Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse 2003 ·Leukemia ·A. Weltermann, Christa Fonatsch, Oskar A. Haas, Hildegard Greinix, (unknown), Gerlinde Mitterbauer, Ulrich Jäger, Birgit Kainz, Klaus Geißler, Peter Valent, Wolfgang R. Sperr, Paul Knöbl, Ilse Schwarzinger, Andreas Gleiß, Klaus Lechner	51
17	Monotherapy with the anti-CD20 antibody rituximab (ritux) in patients with post-transplant lympho-proliferative disease (PTLD). Results of a multicentre phase II study. 2002 ·Data Archiving and Networked Services (DANS) ·(unknown), Kristin Zeidler, (unknown), Petra Reinke, (unknown), Erik A.M. Verschuuren, Ulrich Jäger, Mats Jerkeman, J Niedermeyer, Michael Hallek, Michael Hummel, (unknown), Bernd Doerken, (unknown), (unknown)	2
18	Suspect Cell Convolutes in the Bone Marrow of a Patient with Renal Cell Carcinoma Unmasked as Atypical Convolutes of Hairy Cells 2001 ·Leukemia & lymphoma ·Markus Exner, Renate Thalhammer-Scherrer, Stefan Kudlacek, Ingrid Simonitsch, Ulrich Jäger, (unknown)	0
19	Reciprocal Translocation (3;5)(q26;q22) and Possible BCHE Gene Involvement in an Unusual Myelogenous Disorder with both Myeloproliferative and Dysplastic Features 2000 ·Cancer Genetics and Cytogenetics ·Wolfgang Füreder, Berthold Streubel, (unknown), Sabine Walchshofer, Friedrich Wimazal, Ulrich Jäger, Klaus Geißler, Lawrence B. Schwartz, Andreas Chott, Klaus Lechner, Peter Valent, Christa Fonatsch	2
20	Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis 1998 ·Leukemia ·A. Weltermann, Ingrid Pabinger, Klaus Geißler, Ulrich Jäger, Heinz Gisslinger, Paul Knöbl, Sabine Eichinger, (unknown), Peter Valent, Wolfgang Speiser, Ilse Schwarzinger, Christine Mannhalter, Klaus Lechner	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact